PAI

Palo Alto Investors Portfolio holdings

AUM $470M
1-Year Return 2.57%
This Quarter Return
+0.2%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$645M
AUM Growth
-$124M
Cap. Flow
-$61.9M
Cap. Flow %
-9.6%
Top 10 Hldgs %
76.62%
Holding
47
New
2
Increased
6
Reduced
10
Closed
4

Sector Composition

1 Healthcare 97.26%
2 Financials 2.74%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NVRO
26
DELISTED
NEVRO CORP.
NVRO
$2.79M 0.43%
750,371
MIRM icon
27
Mirum Pharmaceuticals
MIRM
$3.73B
$2.68M 0.41%
64,700
NUVB icon
28
Nuvation Bio
NUVB
$1.07B
$2.06M 0.32%
772,652
TVTX icon
29
Travere Therapeutics
TVTX
$2.09B
$1.93M 0.3%
110,719
PYXS icon
30
Pyxis Oncology
PYXS
$113M
$1.62M 0.25%
1,037,421
+867,421
+510% +$1.35M
VYNE icon
31
VYNE Therapeutics
VYNE
$7.91M
$1.49M 0.23%
445,434
ACRS icon
32
Aclaris Therapeutics
ACRS
$211M
$1.41M 0.22%
569,832
TSHA icon
33
Taysha Gene Therapies
TSHA
$837M
$1.4M 0.22%
811,268
STOK icon
34
Stoke Therapeutics
STOK
$1.29B
$1.39M 0.22%
125,861
ALDX icon
35
Aldeyra Therapeutics
ALDX
$324M
$1.13M 0.17%
225,465
HUM icon
36
Humana
HUM
$33.2B
$1.01M 0.16%
3,985
JSPR icon
37
Jasper Therapeutics
JSPR
$39.5M
$655K 0.1%
+30,651
New +$655K
ABEO icon
38
Abeona Therapeutics
ABEO
$330M
$606K 0.09%
108,865
+96,000
+746% +$535K
URGN icon
39
UroGen Pharma
URGN
$869M
$261K 0.04%
24,500
RLMD icon
40
Relmada Therapeutics
RLMD
$52.8M
$257K 0.04%
495,146
-237,254
-32% -$123K
TIL icon
41
Instil Bio
TIL
$163M
$213K 0.03%
11,165
AKTX
42
Akari Therapeutics
AKTX
$25.7M
$178K 0.03%
+146,024
New +$178K
GBIO icon
43
Generation Bio
GBIO
$39.9M
$160K 0.02%
15,048
BLUE
44
DELISTED
bluebird bio
BLUE
-30,213
Closed -$314K
ELEV
45
DELISTED
Elevation Oncology
ELEV
-1,298,097
Closed -$779K
SAGE
46
DELISTED
Sage Therapeutics
SAGE
-1,010,833
Closed -$7.3M
RVNC
47
DELISTED
Revance Therapeutics, Inc.
RVNC
-1,611,787
Closed -$8.37M